The Pharmaceutical Machinery Industry in China Needs to Speed up the Structural Adjustment

 

The pharmaceutical machinery is the device that directly contacts with the medicine, so it has the most direct impact on the quality of the drug in production. With the continuous improvement of living standards and health concepts of Chinese residents and the continuous increase of government investment in health care, China’s pharmaceutical machinery market will have a fast growth in the future. However, for the moment, our pharmaceutical machinery products are still facing the problem of low added value of products. For this reason, pharmaceutical machinery enterprises need to constantly enhance their structural adjustment and push pharmaceutical machinery products towards the middle and high end.

 

In recent years, although great progress has been made in the development of China’s pharmaceutical machinery industry, there is still a certain gap between China’s pharmaceutical machinery and the world’s. The pharmaceutical machinery and equipment industry in our country is still at the middle and low end of the industrial chain. The rapid growth in the past is more dependent on the strong pull of the domestic market demand and the labor cost advantage.

 

At present, the pharmaceutical machinery industry in our country has encountered more serious problems, which is manifested in the fact that the market cannot accommodate such a large production capacity, and product prices and profits have been at the lowest level in recent years. The low added value of products is the biggest problem in the whole pharmaceutical machinery industry.

 

The proportion of products with high technology, precision and added value is low in our pharmaceutical machinery industry, and the stability of products needs to be further improved. However, affected by the global economic situation in last year, our drug manufacturing industry has also been affected with medicine machine orders greatly reduced, which results in fiercer competition in the overcapacity market and a threat to most enterprises.

 

Therefore, the pharmaceutical machinery enterprises in China need to continuously strengthen the adjustment of the industry structure and improve the added value of products by producing medium and high grade manufactured goods.